Abstract:Ursolic acid (UA) is a major pentacyclic triterpenoid in plants, vegetables and fruits, which has been reported to have a potential anti-diabetic activity. Despite various semi-synthetic ursolic acid derivatives already described, new derivatives still need to be designed and synthesized to further improve the anti-diabetic activity. In the present study, two series of novel UA derivatives, were synthesized and their structures were confirmed. The enzyme inhibition activities of semi-synthesized analogues against α-glucosidase were screened in vitro. The results indicated that most of UA derivatives showed a significant inhibitory activity, especially analogues UA-O-i with the IC50 values of 0.71 ± 0.27 μM, which was more potential than other analogues and the positive control. Furthermore, molecular docking studies were also investigated to verify the in vitro study. Structure modification at the C-3 and C-2 positions of UA was an effective approach to obtain the desired ligand from UA, whose structure was in accordance with the active pocket. Besides, suitable hydrophobic group at the position of C-2 might play an important role for the docking selectivity and binding affinity between the ligand and the homology modelling protein. These results could be helpful for designing more potential α-glucosidase inhibitors from UA in the future.

Synthesis and Biological Evaluation of Ursolic Acid Derivatives As Novel Inhibitors of Glycogen Phosphorylase

Design, Synthesis and Biological Evaluation of Novel Pyrimidinedione Derivatives As DPP-4 Inhibitors.

Synthesis and Evaluation of C-28 Oleanolic Acid Derivatives As Inhibitors of Glycogen Phosphorylase

Synthesis and biological evaluation of novel ursolic acid analogues as potential α-glucosidase inhibitors

Synthesis and biological evaluation of asiatic acid derivatives as inhibitors of glycogen phosphorylases.

Synthesis and Evaluation of Novel Oleanolic Acid Derivatives As Potential Antidiabetic Agents

Synthesis and Biological Activity of Heterocycle-Fused Derivatives of Pentacylic Triterpenes As Glycogen Phosphorylase Inhibitors

Synthesis Of 3-Deoxypentacyclic Triterpene Derivatives As Inhibitors Of Glycogen Phosphorylase

Pentacyclic triterpenes. Part 3: Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase

Synthesis and biological evaluation of novel pyrazolo[4,3-b]oleanane derivatives as inhibitors of glycogen phosphorylase.

Synthesis and Biological Evaluation of Substituted Phenylpyrazole[4,5-B]oleanane Derivatives As Inhibitors of Glycogen Phosphorylase.

Novel therapeutics based on inhibiting the interaction of glycogen phosphorylase and GL-subunit of glycogen-associated protein phosphatase 1: WO2009127723.

Synthesis and Biological Evaluation of Arjunolic Acid, Bayogenin, Hederagonic Acid and 4-Epi-hederagonic Acid as Glycogen Phosphorylase Inhibitors

Synthesis and Biological Evaluation of Ambradiolic Acid As an Inhibitor of Glycogen Phosphorylase

Pentacyclic Triterpenes. Part 5: Synthesis and SAR Study of Corosolic Acid Derivatives As Inhibitors of Glycogen Phosphorylases.

Discovery of Novel Dual-Action Antidiabetic Agents That Inhibit Glycogen Phosphorylase and Activate Glucokinase

Identification of Pentacyclic Triterpenes Derivatives As Potent Inhibitors Against Glycogen Phosphorylase Based on 3D-QSAR Studies

Synthesis of glucoconjugates of oleanolic acid as inhibitors of glycogen phosphorylase.

Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies.

Terpenoids. III: Synthesis and biological evaluation of 23-hydroxybetulinic acid derivatives as novel inhibitors of glycogen phosphorylase.

Exploring Efficacy Of Natural-Derived Acetylphenol Scaffold Inhibitors For Alpha-Glucosidase: Synthesis, In Vitro And In Vivo Biochemical Studies